These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 11789675

  • 41. Delivery of G3139 using releasable PEG-linkers: impact on pharmacokinetic profile and anti-tumor efficacy.
    Zhao H, Peng P, Longley C, Zhang Y, Borowski V, Mehlig M, Reddy P, Xia J, Borchard G, Lipman J, Benimetskaya L, Stein CA.
    J Control Release; 2007 Jun 04; 119(2):143-52. PubMed ID: 17397960
    [Abstract] [Full Text] [Related]

  • 42. The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats.
    Ishida T, Kashima S, Kiwada H.
    J Control Release; 2008 Mar 03; 126(2):162-5. PubMed ID: 18160170
    [Abstract] [Full Text] [Related]

  • 43. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
    Abu Lila AS, Kizuki S, Doi Y, Suzuki T, Ishida T, Kiwada H.
    J Control Release; 2009 Jul 01; 137(1):8-14. PubMed ID: 19285528
    [Abstract] [Full Text] [Related]

  • 44. Effect of Repeated Injections of Adenosine Diphosphate-Encapsulated Liposomes Coated with a Fibrinogen γ-Chain Dodecapeptide Developed as a Synthetic Platelet Substitute on Accelerated Blood Clearance in a Healthy and an Anticancer Drug-Induced Thrombocytopenia Rat Model.
    Taguchi K, Hashimoto M, Ogaki S, Watanabe H, Takeoka S, Ikeda Y, Handa M, Otagiri M, Maruyama T.
    J Pharm Sci; 2015 Sep 01; 104(9):3084-91. PubMed ID: 25755009
    [Abstract] [Full Text] [Related]

  • 45. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid.
    Hatakeyama H, Akita H, Kogure K, Oishi M, Nagasaki Y, Kihira Y, Ueno M, Kobayashi H, Kikuchi H, Harashima H.
    Gene Ther; 2007 Jan 01; 14(1):68-77. PubMed ID: 16915290
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production.
    Tagami T, Nakamura K, Shimizu T, Ishida T, Kiwada H.
    J Control Release; 2009 Aug 04; 137(3):234-40. PubMed ID: 19361546
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
    Yamada A, Taniguchi Y, Kawano K, Honda T, Hattori Y, Maitani Y.
    Clin Cancer Res; 2008 Dec 15; 14(24):8161-8. PubMed ID: 19088031
    [Abstract] [Full Text] [Related]

  • 53. Development of polyethylene glycol-conjugated poly-S-nitrosated serum albumin, a novel S-Nitrosothiol for prolonged delivery of nitric oxide in the blood circulation in vivo.
    Katsumi H, Nishikawa M, Yamashita F, Hashida M.
    J Pharmacol Exp Ther; 2005 Sep 15; 314(3):1117-24. PubMed ID: 15901798
    [Abstract] [Full Text] [Related]

  • 54. [Repeated injection of mitoxantrone containing thermosensitive liposomes in rat induced ABC phenomenon].
    Tian W, Zhang L, Wei N, Li C, Ni BB, Zhao X, Li CL.
    Yao Xue Xue Bao; 2014 Feb 15; 49(2):256-9. PubMed ID: 24761619
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout.
    Sundy JS, Ganson NJ, Kelly SJ, Scarlett EL, Rehrig CD, Huang W, Hershfield MS.
    Arthritis Rheum; 2007 Mar 15; 56(3):1021-8. PubMed ID: 17328081
    [Abstract] [Full Text] [Related]

  • 58. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
    Lopez-Barcons LA, Polo D, Reig F, Fabra A.
    J Biomed Mater Res A; 2004 Apr 01; 69(1):155-63. PubMed ID: 14999763
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.
    Szebeni J, Muggia F, Gabizon A, Barenholz Y.
    Adv Drug Deliv Rev; 2011 Sep 16; 63(12):1020-30. PubMed ID: 21787819
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.